News
Aridis Pharmaceuticals Enrolls Its First COVID-19 Patient in Ongoing Phase 3 AR-301 Clinical Trial in Ventilator Associated Pneumonia
Aridis Pharmaceuticals, Inc., a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening bacterial infections, announced the enrollment...
Press Releases
DNA Genotek’s ORAcollect RNA kit included in EUA granted to Biocerna SARS-CoV-2 test
DNA Genotek Inc., a leading provider of sample collection kits and end-to-end services and a wholly-owned subsidiary of OraSure Technologies, Inc., announced that its...
Press Releases
Astellas Efforts Against the Spread of the Coronavirus Disease (COVID-19)
With more and more Americans facing economic hardships as a result of the COVID-19 pandemic, Astellas has implemented changes to its patient assistance programs...
Packaging & Labelling
United Cargo Meets Growing Demand for Pharmaceuticals with New TempControl Containers
United Cargo announced it will enhance its TempControl service by becoming the first U.S. carrier to lease temperature-controlled shipping containers manufactured by DoKaSch Temperature...
Press Releases
GeoVax and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 Vaccine Development
GeoVax Labs, Inc., a biotechnology company developing human vaccines and immunotherapies against infectious diseases and cancer, announced that Beijing- and Philadelphia-based Sino Biological, Inc....
Press Releases
Quotient Limited Announces CE Mark for its SARS-CoV-2 Antibody Microarray
Quotient Limited, a commercial-stage diagnostics company, headquartered in Eysins, Switzerland, announced that it has completed the process for declaring conformity to the essential requirements...
Press Releases
Notable and MDS Foundation Partner on MDS Trials and New Drug Therapies
California-based Notable announced that it has entered a partnership with the MDS Foundation, which is dedicated to providing insight to families on future clinical...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read